Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC ↓	Name	B/G	Ingredients	Dosage	Form	Price
V03AC03	JADENU	B	Deferasirox - 180mg	180mg	Tablet, film coated	27,151,164 L.L
V03AC03	JADENU	B	Deferasirox - 360mg	360mg	Tablet, film coated	27,151,500 L.L
V03AC03	JADENU	B	Deferasirox - 360mg	360mg	Tablet, film coated	L.L
R05CA12	JOS-PAN	G	Dried Ivy leaf extract (Hederacoside C) - 75mg/100ml		Syrup	306,396 L.L
N07AX01	JAMP PILOCARPINE	G	Pilocarpine HCl - 5mg	5mg	Tablet	3,668,690 L.L
N05AX12	JOSWE ARIPAL 10	G	Aripiprazole - 10mg	10mg	Tablet	2,210,621 L.L
N05AX12	JOSWE ARIPAL 30	G	Aripiprazole - 30mg	30mg	Tablet	4,687,323 L.L
N05AX12	JOSWE ARIPAL 15	G	Aripiprazole - 15mg	15mg	Tablet	2,413,541 L.L
N05AX12	JOSWE ARIPAL 5	G	Aripiprazole - 5mg	5mg	Tablet	1,389,533 L.L
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	258,018 L.L
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	490,503 L.L
N05AH04	JOSWE QUZAL 200	G	Quetiapine - 200mg	200mg	Tablet	1,130,172 L.L
N05AH04	JOSWE QUZAL 200	G	Quetiapine - 200mg	200mg	Tablet	2,147,460 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	2,697,092 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	5,124,071 L.L
M03BX08	JAMP-CYCLOBENZAPRINE	G	Cyclobenzaprine HCl - 10mg	10mg	Tablet	4,031,528 L.L
M01AH05	JOSWE COXIT 120	G	Etoricoxib - 120mg	120mg	Tablet, film coated	517,379 L.L
M01AH01	JOSWE FLAMEX 200	G	Celecoxib - 200mg	200mg	Capsule	225,766 L.L
M01AH01	JOSWE FLAMEX 200	G	Celecoxib - 200mg	200mg	Capsule	636,981 L.L
M01AH01	JOSWE FLAMEX 400	G	Celecoxib - 400mg	400mg	Capsule	588,603 L.L
M01AH01	JOSWE FLAMEX 400	G	Celecoxib - 400mg	400mg	Capsule	1,659,645 L.L
M01AB05	JOFLAM	G	Diclofenac potassium - 50mg	50mg	Tablet, film coated	322,522 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 5mg	5mg	Tablet	172,845,338 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 15mg	15mg	Tablet	341,075,567 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 20mg	20mg	Tablet	341,075,567 L.L
L01CD04	JEVTANA INJECTION	B	Cabazitaxel - 60mg/1.5ml	60mg/1.5ml	Injectable dry powder for solution+diluent	75,619,931 L.L
L01CD04	JEVTANA INJECTION	B	Cabazitaxel - 60mg/1.5ml	60mg/1.5ml	Injectable dry powder for solution+diluent	75,619,931 L.L
J01MA12	JOSWE AVOXIN 500	G	Levofloxacin - 500mg	500mg	Tablet, film coated	786,148 L.L
J01MA12	JOSWE AVOXIN 750	G	Levofloxacin - 750mg	750mg	Tablet, film coated	1,550,794 L.L
J01CR02	JULMENTIN 2X	G	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	278,175 L.L